Cargando…
Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy
Crosstalk of the oncogenic matrix metalloproteinase-9 (MMP9) and one of its ligands, CD44, involves cleavage of CD44 by the MMP9 catalytic domain, with the CD44–MMP9 interaction on the cell surface taking place through the MMP9 hemopexin domain (PEX). This interaction promotes cancer cell migration...
Autores principales: | Yosef, Gal, Hayun, Hezi, Papo, Niv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959692/ https://www.ncbi.nlm.nih.gov/pubmed/33600567 http://dx.doi.org/10.1042/BCJ20200628 |
Ejemplares similares
-
The Dimer Interface of the Membrane Type 1 Matrix Metalloproteinase Hemopexin Domain: CRYSTAL STRUCTURE AND BIOLOGICAL FUNCTIONS
por: Tochowicz, Anna, et al.
Publicado: (2011) -
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
por: Hayun, Hezi, et al.
Publicado: (2023) -
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
por: Hayun, Hezi, et al.
Publicado: (2023) -
Domain architecture divergence leads to functional divergence in binding and catalytic domains of bacterial and fungal cellobiohydrolases
por: Nakamura, Akihiko, et al.
Publicado: (2020) -
A unique cysteine-rich zinc finger domain present in a majority of class II ribonucleotide reductases mediates catalytic turnover
por: Loderer, Christoph, et al.
Publicado: (2017)